Submit Deal
All Dealmakers
Similar Dealmakers
Partner at Davis Polk & Wardwell
Lawyer
New York
Share Profile
Deal Bio
Market Context
Back to top
All rights reserved. Copyright © 2026 Datasite
Expertise (60)
Key Relationships
Sort
Target: STRONGBRIDGE
Bidder: NOVO HOLDINGS AS
4 Service Providers
15 Dealmakers
n/a
Value
Target: ONCOMED PHARMACEUTICALS INC
Bidder: MEREO BIOPHARMA GROUP PLC
11 Service Providers
27 Dealmakers
£ 45 M
Target: SPARK THERAPEUTICS
Bidder: ROCHE HOLDINGS AG
9 Service Providers
29 Dealmakers
£ 3.29 B
Target: PROMEDIOR INC
11 Dealmakers
£ 1.08 B
Target: HEMACARE CORPORATION
Bidder: CHARLES RIVER LABORATORIES INTERNATIONAL INC
8 Service Providers
25 Dealmakers
£ 252 M
Target: CORVIDIA THERAPEUTICS
Bidder: NOVO NORDISK
14 Service Providers
55 Dealmakers
£ 1.65 B
Target: WATER STREET PARTNERS LLC
Bidder: ANKURA CONSULTING GROUP LLC
5 Service Providers
Target: FORBIUS
Bidder: BRISTOL MYERS SQUIBB COMPANY
49 Dealmakers
Target: IMMUNOMEDICS
Bidder: GILEAD SCIENCES
15 Service Providers
50 Dealmakers
£ 16.41 B
Target: KINDRED SYSTEMS INC
Bidder: OCADO GROUP PLC
10 Service Providers
£ 222 M
Target: NINE CONTINENTS MEDICAL
Bidder: COLOPLAST
16 Dealmakers
£ 112 M
Target: EMISPHERE TECHNOLOGIES INC
34 Dealmakers
£ 1.03 B
Target: COGNATE BIOSERVICES
40 Dealmakers
£ 628 M
Target: MDLIVE INC
Bidder: EVERNORTH
20 Dealmakers
£ 1.42 B
Target: SUN WORLD INTERNATIONAL
Bidder: BRIDGEPOINT GROUP
6 Service Providers
12 Dealmakers
Target: ROIVANT SCIENCES LTD
Bidder: MONTES ARCHIMEDES ACQUISITION CORP
16 Service Providers
39 Dealmakers
£ 5.28 B
Target: AGILETHOUGHT
Bidder: LIV CAPITAL ACQUISITION CORP
36 Dealmakers
£ 344 M
Target: VIGENE BIOSCIENCES
32 Dealmakers
£ 248 M
Target: TBCASOFT
Bidder: NAVER CORPORATION
£ 17 M
Target: MCLARTY ASSOCIATES
14 Dealmakers
Target: DICERNA
23 Dealmakers
£ 2.45 B
Target: SENTI BIOSCIENCES
Bidder: DYNAMICS SPECIAL PURPOSE CORPORATION
17 Service Providers
42 Dealmakers
£ 453 M
Target: ENGAGE SURGICAL
Bidder: SMITH & NEPHEW PLC
£ 99 M
Target: NORAGH ANALYTICS
Target: THE HONEST KITCHEN
Bidder: MONARCH ALTERNATIVE CAPITAL
£ 114 M
Target: EXPLORA BIOLABS
£ 224 M
Target: NATUS MEDICAL
Bidder: ARCHIMED SAS
28 Dealmakers
£ 919 M
Target: ACUTUS MEDICAL (LEFT-HEART ACCESS PORTFOLIO)
Bidder: MEDTRONIC PLC
£ 39 M
Target: AFFINIVAX INC
Bidder: GLAXOSMITHKLINE PLC
7 Service Providers
£ 2.61 B
Target: TRANS OVA GENETICS
Bidder: URUS
21 Dealmakers
£ 148 M
Target: MIROBIO
£ 333 M
Target: MOLDED DEVICES
Bidder: TRUARC PARTNERS
17 Dealmakers
Target: FORMA THERAPEUTICS
65 Dealmakers
£ 944 M
Target: OCULIS
Bidder: TEKLA CAPITAL MANAGEMENT LLC
22 Service Providers
31 Dealmakers
£ 194 M
Target: SCHAUENBURG‐TRUPLAST
Bidder: MOLDED DEVICES
Target: MORGENESIS
Bidder: METALMARK CAPITAL LLC
13 Dealmakers
£ 43 M
Target: CONCERT PHARMACEUTICALS
Bidder: SUN PHARMACEUTICAL INDUSTRIES LTD
£ 346 M
Target: CHARTWELL COMPLIANCE
Target: ENGENE INC
Bidder: FORBION EUROPEAN ACQUISITION CORP
19 Dealmakers
£ 196 M
Target: NDA GROUP AB
Bidder: SSI STRATEGY
Target: HIS INNOVATIONS GROUP
Bidder: ULTRA CLEAN HOLDINGS INC
£ 82 M
Target: CARTIHEAL
£ 263 M
Target: LUMIRADX LTD (POINT OF CARE TECHNOLOGY PLATFORM)
3 Service Providers
£ 273 M
Target: HUMANETICS GROUP
Bidder: ANSYS
Target: LUMERI
Target: NOVO HOLDINGS A/S (THREE FILL-FINISH SITES)
53 Dealmakers
£ 8.70 B
Target: CYMABAY THERAPEUTICS
37 Dealmakers
£ 3.40 B
Target: MEYER LAB
Target: ANHEART THERAPEUTICS
Bidder: NUVATION BIO INC
£ 115 M
Target: AOC LLC
Bidder: NIPPON PAINT HOLDINGS
38 Dealmakers
£ 3.35 B
Target: IDRX
56 Dealmakers
£ 941 M
Target: INTRA-CELLULAR THERAPIES INC
Bidder: JOHNSON & JOHNSON
33 Dealmakers
£ 11.96 B
Target: INVUE
Bidder: ASSA ABLOY
Target: REVANCE THERAPEUTICS INC
Bidder: TEOXANE SA
26 Dealmakers
£ 283 M
Target: ENDO INTERNATIONAL PLC
Bidder: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)
139 Dealmakers
£ 5.17 B
Target: PALADIN PHARMA INC
Bidder: KNIGHT THERAPEUTICS INC
£ 77 M
Target: NOVA BIOMEDICAL
Bidder: ADVANCED INSTRUMENTS
£ 1.69 B
Target: METSERA
Bidder: PFIZER INC
98 Dealmakers
£ 7.42 B
Target: CONFORMAL MEDICAL
Bidder: W. L. GORE & ASSOCIATES
Target: PENUMBRA INC
Bidder: BOSTON SCIENTIFIC CORPORATION
£ 10.79 B
